IMM 1.45% 34.0¢ immutep limited

ffxssj,We have hungry US biotech investors waiting at the door...

  1. 5,330 Posts.
    lightbulb Created with Sketch. 32
    ffxssj,

    We have hungry US biotech investors waiting at the door who cleary understand what positive phase3 interim data reporting does to a sp as they were witness to this in 2009 with Dendreon.

    After one report and in less than one month during April 09 the Dendreon sp rallied from US$2.61 to US$22.01 - took a little breather back to US$19.24, then took off again for the next 12 months to a high of US$54.06 in April 2010

    Prima have already announced they expect Phase 3 interim data reporting to start next year

    If you're still holding March 2013 ffxssj I have no doubt there'll be people out there saying they wished they'd got in sub 30c.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.